Immunoclin Corp
company.status.inactiveCIK 1520047fmd_0MQCQZYMT3FSA4HB6NA094VDEVServices · Services-Computer Processing & Data PreparationTemplate: Standard
Coverage: Feb 28, 2011 to Oct 31, 2014, 19 periods
Latest annual · FY2013
Millions- Total revenues
- 0
- Operating income
- (13)
- Net income
- (13)
- Free cash flow
- (0)
Latest quarter · Q3 FY2015
Millions- Total revenues
- 0
- Operating income
- (6)
- Net income
- (6)
- Free cash flow
- 0
Immunoclin Corp financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2014 | FY2013 | Change | Source |
|---|---|---|---|---|
| Operating income | -$13 million | 10-K 2014-07-02 · proof | ||
| Net income | -$13 million | 10-K 2014-07-02 · proof | ||
| Cash from operating activities | -$110,629 | $156,000 | -170.9% | 10-K 2014-07-02 · proof |
| Free cash flow | -$117,219 | 10-K 2014-07-02 · proof | ||
| Total assets | $20.5 million | $202,807 | +10,022.3% | 10-Q 2014-07-24 · proof |
| Total liabilities | $725,468 | $513,195 | +41.4% | 10-K 2014-07-02 · proof |
| Cash and cash equivalents | $51,956 | $167,416 | -69% | 10-K 2014-07-02 · proof |
- What was Immunoclin Corp's operating income in fiscal 2014?
- Immunoclin Corp reported operating income of -$13 million for fiscal 2014 (the year ended Jan 31, 2014). Source: the 10-K filed with the SEC on Jul 2, 2014. SEC
- What was Immunoclin Corp's net income in fiscal 2014?
- Immunoclin Corp reported net income of -$13 million for fiscal 2014 (the year ended Jan 31, 2014). Source: the 10-K filed with the SEC on Jul 2, 2014. SEC
- What was Immunoclin Corp's cash from operating activities in fiscal 2014?
- Immunoclin Corp reported cash from operating activities of -$110,629 for fiscal 2014 (the year ended Jan 31, 2014), against $156,000 the year before (-170.9%). Source: the 10-K filed with the SEC on Jul 2, 2014. SEC
- What was Immunoclin Corp's free cash flow in fiscal 2014?
- Immunoclin Corp reported free cash flow of -$117,219 for fiscal 2014 (the year ended Jan 31, 2014). Source: the 10-K filed with the SEC on Jul 2, 2014. SEC
- What are Immunoclin Corp's total assets?
- As of Jan 31, 2014, Immunoclin Corp reported total assets of $20.5 million, against $202,807 a year earlier (+10,022.3%). Source: the 10-Q filed with the SEC on Jul 24, 2014 (restated). SEC
- What are Immunoclin Corp's total liabilities?
- As of Jan 31, 2014, Immunoclin Corp reported total liabilities of $725,468, against $513,195 a year earlier (+41.4%). Source: the 10-K filed with the SEC on Jul 2, 2014. SEC
- What are Immunoclin Corp's cash and cash equivalents?
- As of Jan 31, 2014, Immunoclin Corp reported cash and cash equivalents of $51,956, against $167,416 a year earlier (-69%). Source: the 10-K filed with the SEC on Jul 2, 2014. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1520047&period_type=annual&limit=5"Information only, not investment advice.